Patents by Inventor Immunogen, Inc.

Immunogen, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel EGFR-Binding Molecules and Immunoconjugates Thereof
    Publication number: 20140099308
    Abstract: Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to EGFR are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.
    Type: Application
    Filed: March 13, 2013
    Publication date: April 10, 2014
    Applicant: ImmunoGen, Inc.
    Inventor: ImmunoGen, Inc.
  • ANTI-CD33 ANTIBODIES AND METHODS FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME
    Publication number: 20130078241
    Abstract: The present invention relates to antibodies that bind CD33. More particularly, the invention relates to anti-CD33 antibodies, fragments and homologues of these antibodies, humanized and resurfaced versions of these antibodies, functional equivalents and improved versions of these antibodies, immunoconjugates and compositions comprising these antibodies, and the uses of same in diagnostic, research and therapeutic applications. The invention also relates to a polynucleotide encoding these antibodies, vectors comprising the polynucleotides, host cells transformed with polynucleotides and methods of producing these antibodies.
    Type: Application
    Filed: November 19, 2012
    Publication date: March 28, 2013
    Applicant: IMMUNOGEN, INC.
    Inventor: Immunogen, Inc.